George Washington University Hematology and Medical Oncology Best Practices On Demand 2026

Description

+ Include:  videos + audios + file sub vtt +  pdf, size:  GB

+ Target Audience: Hematologists, Medical Oncologists, Hematopathologists, Transfusion Medicine Specialists, Neuro-Oncologists, Gynecologic Oncologists, Urologic Oncologists, Gastrointestinal Oncologists, Thoracic Oncologists, Endocrinologists, Dermatologists, Palliative Care Specialists, and Medical Geneticists

+ Sample video: contact me for sample video

+ Information:

The George Washington University Hematology and Medical Oncology Best Practices On Demand course (directed by Robert S. Siegel, MD) is an intensive, high-yield board review program meticulously structured. Featuring national faculty with unmatched expertise, this comprehensive program delivers the latest scientific breakthroughs, practice guidelines, and evidence-based standards of care in cancer prevention, diagnosis, treatment, and survivorship. Available on-demand across computers and mobile devices, the curriculum provides extensive daily board review preparation, cellular morphology analysis, and clinical management updates spanning benign hematology, hematologic malignancies, and solid tumors.

Learning Objectives

At the conclusion of the Hematology and Oncology Best Practices course, the successful learner will be able to:

• Hematology:

  • Understand both established information and recent clinical advances in immunohematology, bone marrow transplantation, and hematopoietic growth factors.

  • Understand both established information and recent clinical advances in coagulopathies, anticoagulant and thrombolytic therapies.

  • Understand blood and marrow morphology and hematopathology.

  • Understand red cell disorders.

• Hematologic Malignancies:

  • Understand the most recent advances in the pharmacology and toxicology of anti-neoplastic drugs.

  • Be familiar with the diagnosis, evaluation, and management of hematologic malignancies.

  • Identify strategies for taking the board examinations.

• Oncology:

  • Understand the epidemiology of malignant diseases and management of the medical complications of malignancy.

  • Understand the principles of management of gynecologic and other genito-urinary malignancies.

  • Recognize the latest advances in cancers of the lung, the breast, and the gastrointestinal tract.

  • Recognize principles of new developments in biologic therapy of cancer.

  • Contend with complexity of HIV related malignancies.

 

Target Audience

• This course is intended for physicians preparing for the in Hematology and Medical Oncology, hematology/oncology fellows-in-training, as well as practicing clinicians and allied healthcare professionals seeking a comprehensive clinical review of standard-of-care practices and recent advances in hematology and oncology.
• Best for Hematologists, Medical Oncologists, Hematopathologists, Transfusion Medicine Specialists, Neuro-Oncologists, Gynecologic Oncologists, Urologic Oncologists, Gastrointestinal Oncologists, Thoracic Oncologists, Endocrinologists, Dermatologists, Palliative Care Specialists, and Medical Geneticists.

Topics

The on-demand curriculum covers the following detailed sessions and lectures:

• Day 0: Hematology / Oncology Enduring Courses

  • Biology of Hematopoiesis

  • Anemia of Chronic Illness

  • Megaloblastic and Sideroblastic Anemias

  • Porphyrias

  • Red Cell Enzymes, Membranes, and Metabolism

  • Mechanisms for Clotting

  • Oral Anticoagulants and Antithrombotic Therapy

  • Parenteral Antithrombotics and Thrombolytic Therapy

  • Review of Cellular Morphology

  • Liquid Biopsies

  • Mesothelioma

• Day 1: Hematology Session

  • ITP and Drug-Induced Thrombocytopenia

  • Hemolytic Anemia

  • Consumptive Thrombohemorrhagic Disorders (DIC, TTP, HUS)

  • The Hemophilias

  • Hypercoagulable States

  • Von Willebrand’s Disease

  • Qualitative Platelet Defects

  • Acquired Disorders of Coagulation

  • Transfusion Medicine

  • Platelet Alloimmunization

• Day 2: Hematology Session

  • Iron Deficiency and Overload

  • Hemoglobinopathies

  • Bone Marrow Failure

  • White Cell Disorders

  • Anti-PF4 Disorders (HIT, VITT), DIC and Ischemic Limb Gangrene

  • Sickling Disorders

  • ABO Incompatibility and Other Transfusion-Related Issues in Hematopoietic Transplantation

  • Hematologic Complications of Pregnancy

• Day 3: Hematologic Malignancies

  • Pathology of Lymphomas

  • Non-Hodgkin’s Lymphoma

  • Myelodysplasia

  • Hodgkin’s Lymphoma

  • Acute Lymphocytic Leukemia

  • Chronic Myeloid Leukemia

  • Multiple Myeloma, Plasmacytoma, and MGUS

  • Waldenstrom’s Macroglobulinemia and Amyloidosis

  • Palliative Care

• Day 4: Hematologic Malignancies

  • Acute Myeloid Leukemia

  • Bone Marrow Transplantation

  • Myeloproliferative Neoplasms

  • Pharmacology I

  • Chronic Lymphocytic Leukemia

  • Pharmacology II

  • Pharmacology III

  • T Cell Therapies for Cancer

• Day 5: Oncology Session

  • Melanoma

  • Familial Cancer Syndromes

  • Non-Small Cell Lung Cancer

  • Small Cell Lung Cancer

  • Adjuvant Therapy for Breast Cancer

  • Metastatic Breast Cancer

  • Neuro-Oncology

  • Metastatic Disease to the Brain, Spine, Carcinomatous Meningitis

  • Endocrine Malignancies

• Day 6: Oncology Session

  • Renal Cell Cancer

  • Prostate Cancer

  • Bladder Cancer

  • Testicular Cancer and Mediastinal Germ Cell Tumors

  • Ovarian Cancer

  • Endometrial Cancer

  • Cancer of the Cervix, Vulva, Vagina and Gestational Trophoblastic Tumors

  • Head and Neck Cancer

  • Carcinoid Tumors, Carcinoid Syndrome and Pancreatic Neuroendocrine Tumors

• Day 7: Oncology Session

  • Esophageal Carcinoma

  • Gastric Cancer

  • Adjuvant Therapy for Colon and Rectal Cancer

  • Pancreatic Cancer

  • Metastatic Therapy for Colon and Rectal Cancer

  • Anal Cancer

  • Sarcoma

  • Hepatobiliary Cancer